Gibson, Dunn & Crutcher LLP is advising Nextech on the matter. Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process...
Relay Therapeutics’ $30 Million Private Placement Financing
Silverback Therapeutics’ Merger With ARS Pharmaceuticals
Cooley represented Silverback, Kirkland & Ellis advised Nextech, Inceptiv Law advised ARS on the deal. Silverback Therapeutics, Inc. (Nasdaq: SBTX) (“Silverback”) and ARS Pharmaceuticals, Inc. (“ARS”)...